Search

Your search keyword '"Pingyong Yi"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Pingyong Yi" Remove constraint Author: "Pingyong Yi"
26 results on '"Pingyong Yi"'

Search Results

1. GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis

2. A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma

3. A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma

4. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

5. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2+ Breast Cancer Cells to 5-Fluorouracil

6. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases

7. A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group

8. Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients

9. Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin

10. A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma

11. A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma

12. Pyrotinib sensitizes 5‑fluorouracil‑resistant HER2-positive breast cancer cells to 5‑fluorouracil

13. A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

14. RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma

15. Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study

16. BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma

17. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

18. Additional file 3: Table S2. of Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

19. Additional file 1: of Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

20. Additional file 2: Table S1. of Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

21. A proposal for a new staging system for extranodal natural killer T-cell lymphoma, nasal type, to predict the treatment strategy: A multicentre study from the Chinese Southwest Oncology Group and Asia Lymphoma Study Group

22. [Clinical analysis of 82 cases of primary mediastinal large B cell lymphoma]

23. ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen

25. [Gene transfer by a novel nonviral vector polyethylenimine]

Catalog

Books, media, physical & digital resources